Mass Spectrometry-Based Identification of MHC-Associated Peptides

Neoantigen-based immunotherapies promise to improve patient outcomes over the current standard of care. However, detecting these cancer-specific antigens is one of the significant challenges in the field of mass spectrometry. Even though the first sequencing of the immunopeptides was done decades ag...

Descripción completa

Detalles Bibliográficos
Autores principales: Kote, Sachin, Pirog, Artur, Bedran, Georges, Alfaro, Javier, Dapic, Irena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139412/
https://www.ncbi.nlm.nih.gov/pubmed/32110973
http://dx.doi.org/10.3390/cancers12030535

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139412/
https://www.ncbi.nlm.nih.gov/pubmed/32110973
http://dx.doi.org/10.3390/cancers12030535

Ejemplares similares